Sexually Transmitted Disease (STD) Diagnosis Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Sexually Transmitted Disease (STD) Diagnosis in Global, including the following market information:
Global Sexually Transmitted Disease (STD) Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sexually Transmitted Disease (STD) Diagnosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chlamydia testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sexually Transmitted Disease (STD) Diagnosis include Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux and Bio-Rad, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sexually Transmitted Disease (STD) Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexually Transmitted Disease (STD) Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sexually Transmitted Disease (STD) Diagnosis Market Segment Percentages, by Type, 2021 (%)
Global Sexually Transmitted Disease (STD) Diagnosis Market Segment Percentages, by Application, 2021 (%)
Global Sexually Transmitted Disease (STD) Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Sexually Transmitted Disease (STD) Diagnosis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sexually Transmitted Disease (STD) Diagnosis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Sexually Transmitted Disease (STD) Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sexually Transmitted Disease (STD) Diagnosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chlamydia testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sexually Transmitted Disease (STD) Diagnosis include Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioMerieux and Bio-Rad, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sexually Transmitted Disease (STD) Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexually Transmitted Disease (STD) Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sexually Transmitted Disease (STD) Diagnosis Market Segment Percentages, by Type, 2021 (%)
- Chlamydia testing
- Syphilis testing
- Gonorrhoea testing
- Herpes simplex virus testing
- Human papilloma virus testing
- Human immunodeficiency virus testing
Global Sexually Transmitted Disease (STD) Diagnosis Market Segment Percentages, by Application, 2021 (%)
- Government organizations
- Hospitals
- Diagnostic clinics
Global Sexually Transmitted Disease (STD) Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Sexually Transmitted Disease (STD) Diagnosis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sexually Transmitted Disease (STD) Diagnosis revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- Roche
- Thermo Fisher Scientific
- Aposcience
- BCR Diagnostics
- BD Medical
- Biocartis
- BioMerieux
- Bio-Rad
- Cepheid
- Danaher
- DiaSorin
- Quidel
- GenMark Diagnostics
- Hologic
- OraSure Technologies
- Qualigen
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Sexually Transmitted Disease (STD) Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS OVERALL MARKET SIZE
2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size: 2021 VS 2028
2.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Sexually Transmitted Disease (STD) Diagnosis Players in Global Market
3.2 Top Global Sexually Transmitted Disease (STD) Diagnosis Companies Ranked by Revenue
3.3 Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Companies
3.4 Top 3 and Top 5 Sexually Transmitted Disease (STD) Diagnosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sexually Transmitted Disease (STD) Diagnosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sexually Transmitted Disease (STD) Diagnosis Players in Global Market
3.6.1 List of Global Tier 1 Sexually Transmitted Disease (STD) Diagnosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Sexually Transmitted Disease (STD) Diagnosis Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Sexually Transmitted Disease (STD) Diagnosis Market Size Markets, 2021 & 2028
4.1.2 Chlamydia testing
4.1.3 Syphilis testing
4.1.4 Gonorrhoea testing
4.1.5 Herpes simplex virus testing
4.1.6 Human papilloma virus testing
4.1.7 Human immunodeficiency virus testing
4.2 By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue & Forecasts
4.2.1 By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2022
4.2.2 By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2023-2028
4.2.3 By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Market Size, 2021 & 2028
5.1.2 Government organizations
5.1.3 Hospitals
5.1.4 Diagnostic clinics
5.2 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue & Forecasts
5.2.1 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2022
5.2.2 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2023-2028
5.2.3 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Market Size, 2021 & 2028
6.2 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue & Forecasts
6.2.1 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2022
6.2.2 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2023-2028
6.2.3 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.3.2 US Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.3.3 Canada Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.3.4 Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.4.2 Germany Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.3 France Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.4 U.K. Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.5 Italy Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.6 Russia Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.7 Nordic Countries Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.8 Benelux Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.5.2 China Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5.3 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5.4 South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5.5 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5.6 India Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.6.2 Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.6.3 Argentina Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.7.2 Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.7.3 Israel Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.7.4 Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.7.5 UAE Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.1.4 Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.2.4 Roche Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Corporate Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.3.4 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.3.5 Thermo Fisher Scientific Key News
7.4 Aposcience
7.4.1 Aposcience Corporate Summary
7.4.2 Aposcience Business Overview
7.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.4.4 Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.4.5 Aposcience Key News
7.5 BCR Diagnostics
7.5.1 BCR Diagnostics Corporate Summary
7.5.2 BCR Diagnostics Business Overview
7.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.5.4 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.5.5 BCR Diagnostics Key News
7.6 BD Medical
7.6.1 BD Medical Corporate Summary
7.6.2 BD Medical Business Overview
7.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.6.4 BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.6.5 BD Medical Key News
7.7 Biocartis
7.7.1 Biocartis Corporate Summary
7.7.2 Biocartis Business Overview
7.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.7.4 Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.7.5 Biocartis Key News
7.8 BioMerieux
7.8.1 BioMerieux Corporate Summary
7.8.2 BioMerieux Business Overview
7.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.8.4 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.8.5 BioMerieux Key News
7.9 Bio-Rad
7.9.1 Bio-Rad Corporate Summary
7.9.2 Bio-Rad Business Overview
7.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.9.4 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.9.5 Bio-Rad Key News
7.10 Cepheid
7.10.1 Cepheid Corporate Summary
7.10.2 Cepheid Business Overview
7.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.10.4 Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.10.5 Cepheid Key News
7.11 Danaher
7.11.1 Danaher Corporate Summary
7.11.2 Danaher Business Overview
7.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.11.4 Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.11.5 Danaher Key News
7.12 DiaSorin
7.12.1 DiaSorin Corporate Summary
7.12.2 DiaSorin Business Overview
7.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.12.4 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.12.5 DiaSorin Key News
7.13 Quidel
7.13.1 Quidel Corporate Summary
7.13.2 Quidel Business Overview
7.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.13.4 Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.13.5 Quidel Key News
7.14 GenMark Diagnostics
7.14.1 GenMark Diagnostics Corporate Summary
7.14.2 GenMark Diagnostics Business Overview
7.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.14.4 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.14.5 GenMark Diagnostics Key News
7.15 Hologic
7.15.1 Hologic Corporate Summary
7.15.2 Hologic Business Overview
7.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.15.4 Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.15.5 Hologic Key News
7.16 OraSure Technologies
7.16.1 OraSure Technologies Corporate Summary
7.16.2 OraSure Technologies Business Overview
7.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.16.4 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.16.5 OraSure Technologies Key News
7.17 Qualigen
7.17.1 Qualigen Corporate Summary
7.17.2 Qualigen Business Overview
7.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.17.4 Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.17.5 Qualigen Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Sexually Transmitted Disease (STD) Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SEXUALLY TRANSMITTED DISEASE (STD) DIAGNOSIS OVERALL MARKET SIZE
2.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size: 2021 VS 2028
2.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Sexually Transmitted Disease (STD) Diagnosis Players in Global Market
3.2 Top Global Sexually Transmitted Disease (STD) Diagnosis Companies Ranked by Revenue
3.3 Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Companies
3.4 Top 3 and Top 5 Sexually Transmitted Disease (STD) Diagnosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sexually Transmitted Disease (STD) Diagnosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sexually Transmitted Disease (STD) Diagnosis Players in Global Market
3.6.1 List of Global Tier 1 Sexually Transmitted Disease (STD) Diagnosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Sexually Transmitted Disease (STD) Diagnosis Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Sexually Transmitted Disease (STD) Diagnosis Market Size Markets, 2021 & 2028
4.1.2 Chlamydia testing
4.1.3 Syphilis testing
4.1.4 Gonorrhoea testing
4.1.5 Herpes simplex virus testing
4.1.6 Human papilloma virus testing
4.1.7 Human immunodeficiency virus testing
4.2 By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue & Forecasts
4.2.1 By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2022
4.2.2 By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2023-2028
4.2.3 By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Market Size, 2021 & 2028
5.1.2 Government organizations
5.1.3 Hospitals
5.1.4 Diagnostic clinics
5.2 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue & Forecasts
5.2.1 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2022
5.2.2 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2023-2028
5.2.3 By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Market Size, 2021 & 2028
6.2 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue & Forecasts
6.2.1 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2022
6.2.2 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2023-2028
6.2.3 By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.3.2 US Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.3.3 Canada Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.3.4 Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.4.2 Germany Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.3 France Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.4 U.K. Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.5 Italy Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.6 Russia Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.7 Nordic Countries Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.4.8 Benelux Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.5.2 China Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5.3 Japan Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5.4 South Korea Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5.5 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.5.6 India Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.6.2 Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.6.3 Argentina Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028
6.7.2 Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.7.3 Israel Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.7.4 Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
6.7.5 UAE Sexually Transmitted Disease (STD) Diagnosis Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.1.4 Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.2.4 Roche Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Corporate Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.3.4 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.3.5 Thermo Fisher Scientific Key News
7.4 Aposcience
7.4.1 Aposcience Corporate Summary
7.4.2 Aposcience Business Overview
7.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.4.4 Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.4.5 Aposcience Key News
7.5 BCR Diagnostics
7.5.1 BCR Diagnostics Corporate Summary
7.5.2 BCR Diagnostics Business Overview
7.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.5.4 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.5.5 BCR Diagnostics Key News
7.6 BD Medical
7.6.1 BD Medical Corporate Summary
7.6.2 BD Medical Business Overview
7.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.6.4 BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.6.5 BD Medical Key News
7.7 Biocartis
7.7.1 Biocartis Corporate Summary
7.7.2 Biocartis Business Overview
7.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.7.4 Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.7.5 Biocartis Key News
7.8 BioMerieux
7.8.1 BioMerieux Corporate Summary
7.8.2 BioMerieux Business Overview
7.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.8.4 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.8.5 BioMerieux Key News
7.9 Bio-Rad
7.9.1 Bio-Rad Corporate Summary
7.9.2 Bio-Rad Business Overview
7.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.9.4 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.9.5 Bio-Rad Key News
7.10 Cepheid
7.10.1 Cepheid Corporate Summary
7.10.2 Cepheid Business Overview
7.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.10.4 Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.10.5 Cepheid Key News
7.11 Danaher
7.11.1 Danaher Corporate Summary
7.11.2 Danaher Business Overview
7.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.11.4 Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.11.5 Danaher Key News
7.12 DiaSorin
7.12.1 DiaSorin Corporate Summary
7.12.2 DiaSorin Business Overview
7.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.12.4 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.12.5 DiaSorin Key News
7.13 Quidel
7.13.1 Quidel Corporate Summary
7.13.2 Quidel Business Overview
7.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.13.4 Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.13.5 Quidel Key News
7.14 GenMark Diagnostics
7.14.1 GenMark Diagnostics Corporate Summary
7.14.2 GenMark Diagnostics Business Overview
7.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.14.4 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.14.5 GenMark Diagnostics Key News
7.15 Hologic
7.15.1 Hologic Corporate Summary
7.15.2 Hologic Business Overview
7.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.15.4 Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.15.5 Hologic Key News
7.16 OraSure Technologies
7.16.1 OraSure Technologies Corporate Summary
7.16.2 OraSure Technologies Business Overview
7.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.16.4 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.16.5 OraSure Technologies Key News
7.17 Qualigen
7.17.1 Qualigen Corporate Summary
7.17.2 Qualigen Business Overview
7.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Major Product Offerings
7.17.4 Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue in Global Market (2017-2022)
7.17.5 Qualigen Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Sexually Transmitted Disease (STD) Diagnosis Market Opportunities & Trends in Global Market
Table 2. Sexually Transmitted Disease (STD) Diagnosis Market Drivers in Global Market
Table 3. Sexually Transmitted Disease (STD) Diagnosis Market Restraints in Global Market
Table 4. Key Players of Sexually Transmitted Disease (STD) Diagnosis in Global Market
Table 5. Top Sexually Transmitted Disease (STD) Diagnosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sexually Transmitted Disease (STD) Diagnosis Product Type
Table 9. List of Global Tier 1 Sexually Transmitted Disease (STD) Diagnosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sexually Transmitted Disease (STD) Diagnosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sexually Transmitted Disease (STD) Diagnosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sexually Transmitted Disease (STD) Diagnosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sexually Transmitted Disease (STD) Diagnosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sexually Transmitted Disease (STD) Diagnosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 32. Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 35. Roche Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 38. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 39. Aposcience Corporate Summary
Table 40. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 41. Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 42. BCR Diagnostics Corporate Summary
Table 43. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 44. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 45. BD Medical Corporate Summary
Table 46. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 47. BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 48. Biocartis Corporate Summary
Table 49. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 50. Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 51. BioMerieux Corporate Summary
Table 52. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 53. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 54. Bio-Rad Corporate Summary
Table 55. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 56. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 57. Cepheid Corporate Summary
Table 58. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 59. Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 60. Danaher Corporate Summary
Table 61. Danaher Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 62. Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 63. DiaSorin Corporate Summary
Table 64. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 65. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 66. Quidel Corporate Summary
Table 67. Quidel Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 68. Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 69. GenMark Diagnostics Corporate Summary
Table 70. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 71. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 72. Hologic Corporate Summary
Table 73. Hologic Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 74. Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 75. OraSure Technologies Corporate Summary
Table 76. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 77. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 78. Qualigen Corporate Summary
Table 79. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 80. Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 1. Sexually Transmitted Disease (STD) Diagnosis Market Opportunities & Trends in Global Market
Table 2. Sexually Transmitted Disease (STD) Diagnosis Market Drivers in Global Market
Table 3. Sexually Transmitted Disease (STD) Diagnosis Market Restraints in Global Market
Table 4. Key Players of Sexually Transmitted Disease (STD) Diagnosis in Global Market
Table 5. Top Sexually Transmitted Disease (STD) Diagnosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sexually Transmitted Disease (STD) Diagnosis Product Type
Table 9. List of Global Tier 1 Sexually Transmitted Disease (STD) Diagnosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sexually Transmitted Disease (STD) Diagnosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sexually Transmitted Disease (STD) Diagnosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sexually Transmitted Disease (STD) Diagnosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sexually Transmitted Disease (STD) Diagnosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sexually Transmitted Disease (STD) Diagnosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 32. Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 35. Roche Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 38. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 39. Aposcience Corporate Summary
Table 40. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 41. Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 42. BCR Diagnostics Corporate Summary
Table 43. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 44. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 45. BD Medical Corporate Summary
Table 46. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 47. BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 48. Biocartis Corporate Summary
Table 49. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 50. Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 51. BioMerieux Corporate Summary
Table 52. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 53. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 54. Bio-Rad Corporate Summary
Table 55. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 56. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 57. Cepheid Corporate Summary
Table 58. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 59. Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 60. Danaher Corporate Summary
Table 61. Danaher Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 62. Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 63. DiaSorin Corporate Summary
Table 64. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 65. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 66. Quidel Corporate Summary
Table 67. Quidel Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 68. Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 69. GenMark Diagnostics Corporate Summary
Table 70. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 71. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 72. Hologic Corporate Summary
Table 73. Hologic Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 74. Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 75. OraSure Technologies Corporate Summary
Table 76. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 77. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
Table 78. Qualigen Corporate Summary
Table 79. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product Offerings
Table 80. Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Sexually Transmitted Disease (STD) Diagnosis Segment by Type in 2021
Figure 2. Sexually Transmitted Disease (STD) Diagnosis Segment by Application in 2021
Figure 3. Global Sexually Transmitted Disease (STD) Diagnosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sexually Transmitted Disease (STD) Diagnosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2021
Figure 8. By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 12. US Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 16. Germany Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 24. China Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 30. Brazil Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 33. Turkey Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Sexually Transmitted Disease (STD) Diagnosis Segment by Type in 2021
Figure 2. Sexually Transmitted Disease (STD) Diagnosis Segment by Application in 2021
Figure 3. Global Sexually Transmitted Disease (STD) Diagnosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sexually Transmitted Disease (STD) Diagnosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sexually Transmitted Disease (STD) Diagnosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sexually Transmitted Disease (STD) Diagnosis Revenue in 2021
Figure 8. By Type - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 12. US Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 16. Germany Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 24. China Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 30. Brazil Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share, 2017-2028
Figure 33. Turkey Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sexually Transmitted Disease (STD) Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
